NCT01340209 Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma Status COMPLETED Phase PHASE3
NCT01339962 Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2. Status COMPLETED Phase N/A
NCT01339546 National Trends in Otitis Media in Children Under 5 Years of Age Status COMPLETED Phase N/A
NCT01339416 HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University Status COMPLETED Phase N/A
NCT01338870 Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01337765 Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients Status COMPLETED Phase PHASE1
NCT01336738 Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT01335061 Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B Status COMPLETED Phase PHASE3
NCT01334554 Study of Sildenafil Citrate on Insulin Resistance in African American Status COMPLETED Phase PHASE1/PHASE2
NCT01334255 iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) Status TERMINATED Phase PHASE1
NCT01334112 Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01327547 A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B Status COMPLETED Phase PHASE4
NCT01326468 Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer Status WITHDRAWN Phase NA
NCT01323270 A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. Status COMPLETED Phase PHASE2
NCT01321463 Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination Status COMPLETED Phase PHASE2